SBI Investment Korea Co., Ltd. through its fund SBI-growth Growth Ladder KONEX Vitalization Fund acquired 2.69% stake in LabGenomics Co., Ltd from Mirae Asset Good Company Investment Fund No.3 and Mirae Asset Venture Investment Co., Ltd. for KRW 1.7 billion.
December 04, 2014 at 04:00 am
Share
SBI Investment Korea Co., Ltd. (KOSDAQ:A019550) through its fund SBI-growth Growth Ladder KONEX Vitalization Fund acquired 2.69% stake in LabGenomics Co., Ltd (KOSDAQ:A084650) from Mirae Asset Good Company Investment Fund No.3 and Mirae Asset Venture Investment Co., Ltd. for KRW 1.7 billion on December 3, 2014.
SBI Investment Korea Co., Ltd. (KOSDAQ:A019550) through its fund SBI-growth Growth Ladder KONEX Vitalization Fund completed the acquisition of 2.69% stake in LabGenomics Co., Ltd (KOSDAQ:A084650) from Mirae Asset Good Company Investment Fund No.3 and Mirae Asset Venture Investment Co., Ltd. on December 3, 2014.
LabGenomics Co., Ltd is a Korea-based company engaged in the provision of in vitro diagnostic (IVD) services. The Company mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Companyâs IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. It also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. It also provides healthy food.
SBI Investment Korea Co., Ltd. through its fund SBI-growth Growth Ladder KONEX Vitalization Fund acquired 2.69% stake in LabGenomics Co., Ltd from Mirae Asset Good Company Investment Fund No.3 and Mirae Asset Venture Investment Co., Ltd. for KRW 1.7 billion.
LABGENOMICS CO., LTD. 